NCT00118742 - Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant | Biotech Hunter

Enrollment

293

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

December 31, 2008

Conditions

Liver Transplantation

Interventions

DRUG

mycophenolate mofetil [CellCept]

1-1.5 g orally or intravenously twice daily

DRUG

Tacrolimus

As prescribed, for 12 months

DRUG

Cyclosporine

As prescribed, for 12 months

DRUG

Sirolimus

2-4 mg orally once daily for 9-11 months

Trial Locations (46)

10016

New York

10029

New York

10032

New York

10532

Hawthorne

19141

Philadelphia

21201

Baltimore

23298

Richmond

27599

Chapel Hill

30322

Atlanta

32216

Jacksonville

33136

Miami

33606

Tampa

35294

Birmingham

37232

Nashville

44195

Cleveland

53792

Madison

55455

Minneapolis

55905

Rochester

60611

Chicago

63110

St Louis

70121

New Orleans

75246

Dallas

77030

Houston

78284

San Antonio

80262

Denver

85054

Phoenix

90095

Los Angeles

92037

La Jolla

94115

San Francisco

90033-4612

Los Angeles

92103-8401

San Diego

94143-0780

San Francisco

60612-3824

Chicago

02111

Boston

02114-2696

Boston

02215

Boston

01805

Burlington

48202-2689

Detroit

07101-1709

Newark

73112-4481

Oklahoma City

97201-3098

Portland

T6G 2B7

Edmonton

B3H 3A7

Halifax

N6A 5A5

London

H2X 3J4

Montreal

H3A 1A1

Montreal

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY